Literature DB >> 1731092

Evolution of the H3 influenza virus hemagglutinin from human and nonhuman hosts.

W J Bean1, M Schell, J Katz, Y Kawaoka, C Naeve, O Gorman, R G Webster.   

Abstract

The nucleotide and amino acid sequences of 40 influenza virus hemagglutinin genes of the H3 serotype from mammalian and avian species and 9 genes of the H4 serotype were compared, and their evolutionary relationships were evaluated. From these relationships, the differences in the mutational characteristics of the viral hemagglutinin in different hosts were examined and the RNA sequence changes that occurred during the generation of the progenitor of the 1968 human pandemic strain were examined. Three major lineages were defined: one containing only equine virus isolates; one containing only avian virus isolates; and one containing avian, swine, and human virus isolates. The human pandemic strain of 1968 was derived from an avian virus most similar to those isolated from ducks in Asia, and the transfer of this virus to humans probably occurred in 1965. Since then, the human viruses have diverged from this progenitor, with the accumulation of approximately 7.9 nucleotide and 3.4 amino acid substitutions per year. Reconstruction of the sequence of the hypothetical ancestral strain at the avian-human transition indicated that only 6 amino acids in the mature hemagglutinin molecule were changed during the transition between an avian virus strain and a human pandemic strain. All of these changes are located in regions of the molecule known to affect receptor binding and antigenicity. Unlike the human H3 influenza virus strains, the equine virus isolates have no close relatives in other species and appear to have diverged from the avian viruses much earlier than did the human virus strains. Mutations were estimated to have accumulated in the equine virus lineage at approximately 3.1 nucleotides and 0.8 amino acids per year. Four swine virus isolates in the analysis each appeared to have been introduced into pigs independently, with two derived from human viruses and two from avian viruses. A comparison of the coding and noncoding mutations in the mammalian and avian lineages showed a significantly lower ratio of coding to total nucleotide changes in the avian viruses. Additionally, the avian virus lineages of both the H3 and H4 serotypes, but not the mammalian virus lineages, showed significantly greater conservation of amino acid sequence in the internal branches of the phylogenetic tree than in the terminal branches. The small number of amino acid differences between the avian viruses and the progenitor of the 1968 pandemic strain and the great phenotypic stability of the avian viruses suggest that strains similar to the progenitor strain will continue to circulate in birds and will be available for reintroduction into humans.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1731092      PMCID: PMC240817     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Evolution of the nucleoprotein gene of influenza A virus.

Authors:  O T Gorman; W J Bean; Y Kawaoka; R G Webster
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

2.  Complete structure of the hemagglutinin gene from the human influenza A/Victoria/3/75 (H3N2) strain as determined from cloned DNA.

Authors:  W M Jou; M Verhoeyen; R Devos; E Saman; R Fang; D Huylebroeck; W Fiers; G Threlfall; C Barber; N Carey; S Emtage
Journal:  Cell       Date:  1980-03       Impact factor: 41.582

3.  Complete structure of A/duck/Ukraine/63 influenza hemagglutinin gene: animal virus as progenitor of human H3 Hong Kong 1968 influenza hemagglutinin.

Authors:  R Fang; W Min Jou; D Huylebroeck; R Devos; W Fiers
Journal:  Cell       Date:  1981-08       Impact factor: 41.582

4.  Conservation and variation in the hemagglutinins of Hong Kong subtype influenza viruses during antigenic drift.

Authors:  G W Both; M J Sleigh
Journal:  J Virol       Date:  1981-09       Impact factor: 5.103

5.  Sequence of the hemagglutinin gene of influenza virus A/Memphis/1/71 and previously uncharacterized monoclonal antibody-derived variants.

Authors:  S E Newton; G M Air; R G Webster; W G Laver
Journal:  Virology       Date:  1983-07-30       Impact factor: 3.616

6.  Nucleotide sequence of the haemagglutinin gene of influenza virus A/England/321/77.

Authors:  R Hauptmann; L D Clarke; R C Mountford; H Bachmayer; J W Almond
Journal:  J Gen Virol       Date:  1983-01       Impact factor: 3.891

7.  Evidence for the natural transmission of influenza A virus from wild ducts to swine and its potential importance for man.

Authors:  M Pensaert; K Ottis; J Vandeputte; M M Kaplan; P A Bachmann
Journal:  Bull World Health Organ       Date:  1981       Impact factor: 9.408

8.  Antigenic drift in the hemagglutinin of the Hong Kong influenza subtype: correlation of amino acid changes with alterations in viral antigenicity.

Authors:  M J Sleigh; G W Both; P A Underwood; V J Bender
Journal:  J Virol       Date:  1981-03       Impact factor: 5.103

9.  Sequence relationships among the hemagglutinin genes of 12 subtypes of influenza A virus.

Authors:  G M Air
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

10.  Mutations in the hemagglutinin receptor-binding site can change the biological properties of an influenza virus.

Authors:  C W Naeve; V S Hinshaw; R G Webster
Journal:  J Virol       Date:  1984-08       Impact factor: 5.103

View more
  75 in total

1.  Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals.

Authors:  M Matrosovich; A Tuzikov; N Bovin; A Gambaryan; A Klimov; M R Castrucci; I Donatelli; Y Kawaoka
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

Review 2.  Influenza vaccines: from surveillance through production to protection.

Authors:  Pritish K Tosh; Robert M Jacobson; Gregory A Poland
Journal:  Mayo Clin Proc       Date:  2010-01-29       Impact factor: 7.616

3.  Mutations during the Adaptation of H9N2 Avian Influenza Virus to the Respiratory Epithelium of Pigs Enhance Sialic Acid Binding Activity and Virulence in Mice.

Authors:  W Yang; D Punyadarsaniya; R L O Lambertz; D C C Lee; C H Liang; D Höper; S R Leist; A Hernández-Cáceres; J Stech; M Beer; C Y Wu; C H Wong; K Schughart; F Meng; G Herrler
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

4.  Phylogenic analysis of the M genes of influenza viruses isolated from free-flying water birds from their Northern Territory to Hokkaido, Japan.

Authors:  Rashid Manzoor; Yoshihiro Sakoda; Aaron Mweene; Yoshimi Tsuda; Noriko Kishida; Gui-Rong Bai; Ken-Ichiro Kameyama; Norikazu Isoda; Kosuke Soda; Michiko Naito; Hiroshi Kida
Journal:  Virus Genes       Date:  2008-07-10       Impact factor: 2.332

Review 5.  Evolution and ecology of influenza A viruses.

Authors:  R G Webster; W J Bean; O T Gorman; T M Chambers; Y Kawaoka
Journal:  Microbiol Rev       Date:  1992-03

6.  Infection of human airway epithelium by human and avian strains of influenza a virus.

Authors:  Catherine I Thompson; Wendy S Barclay; Maria C Zambon; Raymond J Pickles
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

7.  Origin and evolution of the 1918 "Spanish" influenza virus hemagglutinin gene.

Authors:  A H Reid; T G Fanning; J V Hultin; J K Taubenberger
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

8.  Perpetuation of influenza A viruses in Alaskan waterfowl reservoirs.

Authors:  T Ito; K Okazaki; Y Kawaoka; A Takada; R G Webster; H Kida
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

9.  Effect of vaccine use in the evolution of Mexican lineage H5N2 avian influenza virus.

Authors:  Chang-Won Lee; Dennis A Senne; David L Suarez
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

10.  Influenza virus subtypes in aquatic birds of eastern Germany.

Authors:  J Süss; J Schäfer; H Sinnecker; R G Webster
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.